BERKELEY, CA — A
biologically active glass that enables metal implants to bond with bone
could significantly extend the lifetime of artificial hips, knees, and
other medical reconstructive devices. The bioactive glass coating is being
developed by researchers with the U.S. Department of Energy's Lawrence
Berkeley National Laboratory (Berkeley Lab).
|
NEW BIOACTIVE GLASS CAN BE TUNED TO THE SAME THERMAL EXPANSION
COEFFICIENT AS THE TITANIUM ALLOY IT COATS, AVOIDING THE GENERATION
OF THERMAL STRESSES. PROCESSING AT 800°C RESULTS IN A
100-NANOMETER-THICK ADHESIVE INTERFACE LAYER BETWEEN THE GLASS
COATING AND THE ALLOY.
|
More than $2 billion is spent yearly in this country on hip and knee
implants, plates and pins for broken bones, dental implants, and other
reconstructions. An estimated 11 million persons in the United States have
at least one such medical implant and this number is growing as the
population receiving implants increases.
Most implants today are made from either titanium-based alloys or
alloys made from a mix of cobalt and chromium. Both possess excellent
mechanical properties but neither is able to bond with bone. As a result,
these metals rub against the bones into which they've been implanted,
creating wear and tear that shortens implant lifetimes. For example,
according to the National Center for Health Statistics, hip implants
generally fail after 15 years and one out of every five hip-replacement
surgeries is performed to replace one of these failed implants.
"What has been needed is a coating that adheres to the metal
surface of the implant and also promotes the formation of hydroxyapatite
(the inorganic component of bone)," says Antoni Tomsia, a materials
scientist with Berkeley Lab's Materials Sciences Division which has
maintained a long-term program for the study of ceramic/metal interfaces.
Working with physicist Eduardo Saiz, Tomsia has developed a silicate
glass that is bioactive, and a simple "enameling procedure"
whereby metal implants can be coated with micron-sized (20-200 microns
thick) layers of this glass. These glass layers can be fine-tuned at the
metal-glass and glass-bone interfaces so that the coating binds with both
metal and bone.
|
EDUARDO SAIZ (LEFT) AND ANTONI TOMSIA PICTURED IN THEIR
LABORATORY
|
"It is impossible to design a single coating that will serve all
purposes, so what we have done is to create a set of two to three graded
layers of coating," says Tomsia. "The glass is cheap to make and
the enameling is inexpensive."
In the enameling process used by Tomsia and Saiz, precursor powders are
painted on the metal surface and the implant is then annealed at
temperatures of 800 to 900 degrees Celsius. Titanium and cobalt-chromium
remain solid at these temperatures but the glass becomes liquid. The
liquid glass will uniformly coat the surface of even the most intricately
shaped implant, a marked advantage over plasma coatings that must be
sprayed onto a surface.
There have been previous tests of ceramic coatings on metal implant
surfaces but the rates at which the ceramics and metals expanded under the
heat of processing differed so much that large stresses were introduced.
These thermal stresses led to cracks in the ceramics at the metal
interface, which weakened the adhesion between the two surfaces.
Furthermore, chemical reactions between the ceramic and the metal,
particularly titanium, weakened the implant.
"We can adjust our coatings so that the thermal coefficient of the
glass matches that of the metal alloy," says Tomsia. "This
eliminates the introduction of thermal stresses during processing."
Tests with titanium and cobalt-chromium showed that the inner surface
of the bioactive glass coating of Tomsia and Saiz adheres to the metal
without degradation. Upon exposure to simulated body fluid during in vitro
testing, a layer of hydroxyapatite will form on the coating's outer
surface.
"Implants that are more durable and longer lasting will promote
faster healing rates and should be accessible to a wider range of
patients," says Tomsia. Over the next year, he and Saiz will be
extending their studies to in vivo testing on animal models.
This research was funded by the National Institute for Dental and
Craniofacial Research of the National Institutes of Health. Berkeley Lab
is a U.S. Department of Energy national laboratory located in Berkeley,
California. It conducts unclassified scientific research and is managed by
the University of California.
|